REPLIMUNE GROUP, INC. Increase (Decrease) in Prepaid Expense and Other Assets
REPLIMUNE GROUP, INC. (REPL) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$3.13 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- REPLIMUNE GROUP, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$3.13M.
- REPLIMUNE GROUP, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $362.00K, a 3.13% increase year-over-year.
- REPLIMUNE GROUP, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$36.00K.
- REPLIMUNE GROUP, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $140.00K, a 93.71% decline year-over-year.
- REPLIMUNE GROUP, INC. increase (decrease) in prepaid expense and other assets for fiscal 2026 was $232.00K, a 7.94% decline from fiscal 2025.
- REPLIMUNE GROUP, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $252.00K, a 85.83% decline from fiscal 2024.
- REPLIMUNE GROUP, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.78M, a 67.89% increase from fiscal 2023.
- REPLIMUNE GROUP, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $1.06M, a 29.94% increase from fiscal 2022.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.13M 10-Q · filed 2026-08-14 | -$2.77M derived: sum of 2 quarters · filed 2026-08-14 | -$2.80M derived: sum of 3 quarters · filed 2026-08-14 | -$2.66M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $326.00K derived: sum of 2 quarters · filed 2026-06-29 | $466.00K derived: sum of 3 quarters · filed 2026-06-29 | $232.00K 10-K · filed 2026-06-29 |
| 2025-12-31 | -$36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-03 | $104.00K derived: sum of 2 quarters · filed 2026-02-03 | -$130.00K 10-Q · filed 2026-02-03 | $221.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | $140.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | -$94.00K 10-Q · filed 2025-11-06 | $257.00K derived: sum of 3 quarters · filed 2026-08-14 | -$249.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$234.00K 10-Q · filed 2026-08-14 | $117.00K derived: sum of 2 quarters · filed 2026-08-14 | -$389.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.83M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | -$155.00K derived: sum of 2 quarters · filed 2026-06-29 | $2.07M derived: sum of 3 quarters · filed 2026-06-29 | $252.00K 10-K · filed 2026-06-29 |
| 2024-12-31 | -$506.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-03 | $1.72M derived: sum of 2 quarters · filed 2026-02-03 | -$99.00K 10-Q · filed 2026-02-03 | -$532.00K derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $2.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $407.00K 10-Q · filed 2025-11-06 | -$26.00K derived: sum of 3 quarters · filed 2025-11-06 | -$58.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$1.82M 10-Q · filed 2025-08-07 | -$2.25M derived: sum of 2 quarters · filed 2025-08-07 | -$2.28M derived: sum of 3 quarters · filed 2025-08-07 | -$1.62M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$433.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | -$465.00K derived: sum of 2 quarters · filed 2025-05-22 | $201.00K derived: sum of 3 quarters · filed 2025-05-22 | $1.78M 10-K · filed 2025-05-22 |
| 2023-12-31 | -$32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-12 | $634.00K derived: sum of 2 quarters · filed 2025-02-12 | $2.21M 10-Q · filed 2025-02-12 | $2.87M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $666.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | $2.24M 10-Q · filed 2024-11-12 | $2.91M derived: sum of 3 quarters · filed 2024-11-12 | $3.46M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.58M 10-Q · filed 2024-08-08 | $2.24M derived: sum of 2 quarters · filed 2024-08-08 | $2.79M derived: sum of 3 quarters · filed 2024-08-08 | $3.79M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $1.22M derived: sum of 2 quarters · filed 2024-05-16 | $2.22M derived: sum of 3 quarters · filed 2024-05-16 | $1.06M 10-K · filed 2024-05-16 |
| 2022-12-31 | $555.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $1.55M derived: sum of 2 quarters · filed 2024-02-08 | $396.00K 10-Q · filed 2024-02-08 | $277.00K derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | $999.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | -$159.00K 10-Q · filed 2023-11-07 | -$278.00K derived: sum of 3 quarters · filed 2023-11-07 | -$596.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$1.16M 10-Q · filed 2023-08-03 | -$1.28M derived: sum of 2 quarters · filed 2023-08-03 | -$1.59M derived: sum of 3 quarters · filed 2023-08-03 | $885.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | -$437.00K derived: sum of 2 quarters · filed 2023-05-18 | $2.04M derived: sum of 3 quarters · filed 2023-05-18 | $815.00K 10-K · filed 2023-05-18 |
| 2021-12-31 | -$318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | $2.16M derived: sum of 2 quarters · filed 2023-02-09 | $934.00K 10-Q · filed 2023-02-09 | $1.40M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | $1.25M 10-Q · filed 2022-11-03 | $1.72M derived: sum of 3 quarters · filed 2022-11-03 | $1.03M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$1.23M 10-Q · filed 2022-08-04 | -$759.00K derived: sum of 2 quarters · filed 2022-08-04 | -$1.45M derived: sum of 3 quarters · filed 2022-08-04 | $178.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $469.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | -$225.00K derived: sum of 2 quarters · filed 2022-05-19 | $1.41M derived: sum of 3 quarters · filed 2022-05-19 | $1.71M 10-K · filed 2022-05-19 |
| 2020-12-31 | -$694.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-03 | $937.00K derived: sum of 2 quarters · filed 2022-02-03 | $1.24M 10-Q · filed 2022-02-03 | -$1.22M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-09-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-04 | $1.93M 10-Q · filed 2021-11-04 | -$521.00K derived: sum of 3 quarters · filed 2021-11-04 | -$1.13M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $301.00K 10-Q · filed 2021-08-06 | -$2.15M derived: sum of 2 quarters · filed 2021-08-06 | -$2.76M derived: sum of 3 quarters · filed 2021-08-06 | -$1.48M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | -$2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-20 | -$3.06M derived: sum of 2 quarters · filed 2021-05-20 | -$1.78M derived: sum of 3 quarters · filed 2021-05-20 | -$933.00K 10-K · filed 2021-05-20 |
| 2019-12-31 | -$608.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-04 | $673.00K derived: sum of 2 quarters · filed 2021-02-04 | $1.52M 10-Q · filed 2021-02-04 | $1.73M derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | $2.13M 10-Q · filed 2020-11-05 | $2.34M derived: sum of 3 quarters · filed 2020-11-05 | $1.90M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $847.00K 10-Q · filed 2020-08-07 | $1.06M derived: sum of 2 quarters · filed 2020-08-07 | $614.00K derived: sum of 3 quarters · filed 2020-08-07 | $1.43M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | -$233.00K derived: sum of 2 quarters · filed 2020-06-03 | $581.00K derived: sum of 3 quarters · filed 2020-06-03 | $801.00K 10-K · filed 2020-06-03 |
| 2018-12-31 | -$445.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-13 | $369.00K derived: sum of 2 quarters · filed 2020-02-13 | $589.00K 10-Q · filed 2020-02-13 | $389.00K derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-09-30 | $814.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-12 | $1.03M 10-Q · filed 2019-11-12 | $834.00K derived: sum of 3 quarters · filed 2020-06-03 | $312.00K derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-06-30 | $220.00K 10-Q · filed 2019-08-14 | $20.00K derived: sum of 2 quarters · filed 2020-06-03 | -$502.00K derived: sum of 3 quarters · filed 2020-06-03 | -$731.00K derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-03-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | -$722.00K derived: sum of 2 quarters · filed 2020-06-03 | -$951.00K derived: sum of 3 quarters · filed 2020-06-03 | $305.00K 10-K · filed 2020-06-03 |
| 2017-12-31 | -$522.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | -$751.00K derived: sum of 2 quarters · filed 2019-02-14 | $505.00K 10-Q · filed 2019-02-14 | |
| 2017-09-30 | -$229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-14 | $1.03M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $1.26M 10-Q · filed 2018-08-30 | |||
| 2017-03-31 | $325.00K 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |